Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

NCT00887107 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT00887107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma
Lead sponsor
Leiden University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
Not reported
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer